Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-09T20:00:01.000Z.
Quote observation: 2026-09-09T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bef7f289391c7460483e20d6a2b52610481c87f785e36ab51e0e8a2f1a0a8930
PEG RATIO
N/A
Moderna, Inc.
Market Cap
$53.81B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Moderna, Inc. (MRNA) | $53.81B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $56.21B | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $49.62B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $49.54B | N/A |
| Humana Inc. (HUM)vs › | $48.03B | N/A |
| Cencora, Inc. (COR)vs › | $62.91B | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.92B | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $42.30B | N/A |
| Agilent Technologies, Inc. (A)vs › | $40.89B | N/A |
| Boston Scientific Corporation (BSX)vs › | $66.83B | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
